Trial Profile
Randomized Phase II Clinical Study of Radiation Therapy, Hormone Therapy and Chemotherapy With Docetaxel Versus Radiation Therapy and Hormone Therapy in Patients With High-Risk Localized Prostate Cancer (Stage III and IV)"
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Nov 2023
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Hormone antagonists
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms QRT-SOGUG
- 21 Nov 2023 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Jan 2021).
- 06 Jul 2011 New trial record